Dengxuan Fan

Dr. Dengxuan Fan

Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, P.R. China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Clinical Immunology
Verified
Journal Article
Closed access
DFDengxuan Fan
Dengxuan Fan
JDJie Duan
Jie Duan
MLMingqing Li
Mingqing Li
BXBin Xu
Bin Xu
DLDa-Jin Li
Da-Jin Li
LJLi-Ping Jin
Li-Ping Jin

11 April 2011 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
LJLi-Ping Jin
Li-Ping Jin
DFDengxuan Fan
Dengxuan Fan
TZTai Zhang
Tai Zhang
PGPei-Fen Guo
Pei-Fen Guo
DLDa-Jin Li
Da-Jin Li

23 January 2020 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
JSJia‐Wei Shi
Jia‐Wei Shi
HYHui‐Li Yang
Hui‐Li Yang
DFDengxuan Fan
Dengxuan Fan
SYShao‐Liang Yang
Shao‐Liang Yang
XQXue‐Min Qiu
Xue‐Min Qiu
MLMingqing Li
Mingqing Li

1 April 2019 in Reproductive Sciences
Verified
Journal Article
Open access
PDF file
DFDengxuan Fan
Dengxuan Fan
WZWen-Jie Zhou
Wen-Jie Zhou
LJLi-Ping Jin
Li-Ping Jin
MLMing-Qing Li
Ming-Qing Li
XXXiangh-Hong Xu
Xiangh-Hong Xu
CXCongjian Xu
Congjian Xu
Decidual γδ T cells are known to regulate the function of trophoblasts at the maternal–fetal interface; however, little is known about the molecular mechanisms of cross talk between trophoblast cells and decidual γδ T cells. Expression of chemokine C-X-C motif ligand 6 (CXCL16) and its receptor CXCR6 was evaluated in first-trimester human villus and decidual tissues by immunohistochemistry. γδ T cells were isolated from first-trimester human deciduae and cocultured with JEG3 trophoblast cells. Cell proliferation and apoptosis-related molecules, together with cytotoxicity factor and cytokine production, were measured by flow cytometry analysis. Expression of CXCL16 and CXCR6 was reduced at the maternal–fetal interface in patients who experienced unexplained recurrent spontaneous abortion as compared to healthy pregnancy women. With the administration of pregnancy-related hormones or coculture with JEG3 cells, CXCR6 expression was upregulated on decidual γδ T cells. CXCL16 derived from JEG3 cells caused a decrease in granzyme B production of decidual γδ T cells. In addition, decidual γδ T cells educated by JEG3-derived CXCL16 upregulated the expression of Bcl-xL in JEG3 cells. This study suggested that the CXCL16/CXCR6 axis may contribute to maintaining normal pregnancy by reducing the secretion of cytotoxic factor granzyme B of decidual γδ T cells and promoting the expression of antiapoptotic marker Bcl-xL of trophoblasts.

1 July 2014 in Fertility and Sterility
Verified
Journal Article
Closed access
YWYing Wang
Ying Wang
YZYuan Zhang
Yuan Zhang
MLMing-Qing Li
Ming-Qing Li
DFDengxuan Fan
Dengxuan Fan
XWXiao-Hui Wang
Xiao-Hui Wang
LJLi-Ping Jin
Li-Ping Jin

25 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
DFDengxuan Fan
Dengxuan Fan
HYHailing Yang
Hailing Yang
WMWeiqun Mao
Weiqun Mao
PRPhilip J. Rask
Philip J. Rask
LPLan Pang
Lan Pang
ZLZhen Lu
Zhen Lu
Salt-induced kinase 2 (SIK2) is a serine-threonine kinase that regulates centrosome splitting, activation of PI3 kinase and phosphorylation of class IIa HDACs, affecting gene expression. Previously, we found that inhibition of SIK2 enhanced sensitivity of ovarian cancer cells to paclitaxel. Carboplatin and paclitaxel constitute first-line therapy for most patients with ovarian carcinoma, producing a 70% clinical response rate, but curing <20% of patients with advanced disease. We have asked whether inhibition of SIK2 with ARN-3261 enhances sensitivity to carboplatin in ovarian cancer cell lines and xenograft models. ARN-3261-induced DNA damage and apoptosis were measured with γ-H2AX accumulation, comet assays, and annexin V. ARN-3261 inhibited growth of eight ovarian cancer cell lines at an IC50 of 0.8 to 3.5 µM. ARN-3261 significantly enhanced sensitivity to carboplatin in seven of eight ovarian cancer cell lines and a carboplatin-resistant cell line tested. Furthermore, ARN-3261 in combination with carboplatin produced greater inhibition of tumor growth than carboplatin alone in SKOv3 and OVCAR8 ovarian cancer xenograft models. ARN-3261 enhanced DNA damage and apoptosis by downregulating expression of survivin. Thus, a SIK2 kinase inhibitor enhanced carboplatin-induced therapy in preclinical models of ovarian cancer and deserves further evaluation in clinical trials.